Colitis

Disease3 papers

Animals3

Trial sponsors

M.D. Anderson Cancer Center
2 trialsPhase 1840 people

Funding

National Institute of Diabetes and Digestive and Kidney DiseasesUS$567.6k1 grant since 2024

AHR-NLRP6 interactions in gut barrier dysfunction and colitis
National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of LouisvilleUS$567.6k2024–2028

Latest

7

Journal, Genetic Engineering & BiotechnologyIn silico16 Sep

The bioinformatics approach to identifying pathogenic variants for colorectal cancer (CRC)

Colorectal cancer

Aging CellAnimals10 Sep

NAD⁺ Metabolic Reprogramming Drives CD8⁺ T Cells Senescence and Exacerbates Ulcerative Colitis

Blood and immune system

bioRxivAnimalsPreprint4 Sep

Transthyretin Contributes to Hippocampal Blood-Brain Barrier Recovery Following Intestinal Inflammation, with Reduced Expression in Alzheimer's Disease

Environment InternationalHumans3 Sep

Mortality study of a PFOA-exposed cohort in the mid-Ohio Valley

Frontiers in NutritionAnimals1 Sep

Alternate-day fasting increases the risk of decreased immune cells and anemia in DSS-induced colitis mice

Biochemistry and Biophysics ReportsAnimals26 Aug

NAD⁺ metabolism influences TGF-β-associated transcriptional programs and the gut microbiota in murine models of colitis

Gut and microbiome

Inflammatory Bowel DiseasesHumans21 Aug

GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study

GLP-1 receptor agonists